SEC Form SC 13G filed by Seelos Therapeutics Inc.

Seelos Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.001

(Title of Class of Securities)

81577F406

(CUSIP Number)

October 31, 2024

(Date of Event Which Requires Filing of the Statement)

☒

Rule 13d-1(b)

☐

Rule 13d-1(c)

☐

Rule 13d-1(d)

Cusip No. 81577F406

Page 2 of 5 Pages

1.	NAME OF REPORTING PERSONS   AdvisorShares Trust
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a)  ☐     (b)  ☐
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5.	SOLE VOTING POWER	152,444
		6.	SHARED VOTING POWER	0
		7.	SOLE DISPOSITIVE POWER	152,444
		8.	SHARED DISPOSITIVE POWER	0
9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON			152,444
10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES			☐
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)			34.96%
12.	TYPE OF REPORTING PERSON (See Instructions)			IV

Item 1(a).

Name of Issuer:  Seelos Therapeutics, Inc.

Item 1(b).

Address of Issuer’s Principal Executive Offices:

Item 2(a).

Name of Person Filing: AdvisorShares Trust

Item 2(b).

Address of Principal Business Office or, if none, Residence:

Item 2(c).

Citizenship: Delaware

Item 2(d).

Title of Class of Securities: Common Stock, par value, $0.001

Item 2(e).

CUSIP Number: 81577F406

Item 3.

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

	(a)	[  ]	Broker or dealer registered under Section 15 of the Act (15 U.S.C 78o);
	(b)	[  ]	Bank as defined in Section 3(a)(6) of the Act (15 U.S.C 78c);
	(c)	[  ]	Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C 78c);
	(d)	[X]	Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
	(e)	[ ]	An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
	(f)	[  ]	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
	(g)	[  ]	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
	(h)	[  ]	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	[  ]	A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
	(j)	[  ]	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
	(k)	[   ]	Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership:

(a)

Amount beneficially owned:  152,444

(b)

Percent of Class: 34.96%

(c)

Number of shares as to which such person has:

(i)

sole power to vote or to direct the vote: 152,444

(ii)

shared power to vote or to direct the vote: 0

(iii)

sole power to dispose or to direct the disposition of: 152,444

(iv)

shared power to dispose or to direct the disposition of: 0

Item 5.

Ownership of Five Percent or Less of a Class:

Item 6.

Ownership of More than Five Percent on Behalf of Another Person:

Item 7.

Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Item 8.

Identification and Classification of Members of the Group:

Item 9.

Notice of Dissolution of Group:

	November 5, 2024
	(Date)
	/s/ Stefanie Little
	(Signature)
	Stefanie Little – Chief Compliance Officer
	Name and Title